About Yuva Biosciences
Yuva Biosciences is a private company based in Birmingham, Alabama. It has reported $1,118,000 raised in two offerings on Form D since November 2023. Its chief executive is Greg Schmergel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 24, 2026 | $1,118,000of $3.0M target | 11 | $101K | Options, Securities on exercise, Simple Agreements for Future Equity (SAFEs) and equity securities of Issuer into which SAFEs may convertRule 506(b) | Form D ↗ |
| Not yet | Nov 7, 2023 | $0of $4.5M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,118,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Yuva Biosciences's Form D filed Mar 24, 2026.
